Sutimlimab
Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.
Product Specifications
CAS Number
2049079-64-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Complement System
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7136972-01 0.02 mg (E-Coli)
Recombinant Salmonella typhimurium Beta-lactamase CTX-M-2 (bla)
Sign In for Pricing
View Details MBS7136972-02 0.1 mg (E-Coli)
Recombinant Salmonella typhimurium Beta-lactamase CTX-M-2 (bla)
Sign In for Pricing
View Details